We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFX icon
51
Teleflex
TFX
$5.96B
$1.34M 0.39%
3,262
+2,829
+653% +$1.04M
META icon
52
CALL
Meta Platforms (Facebook)
META
$1.49T
$1.33M 0.39%
+100
New +$27.4K
FCEL icon
53
FuelCell Energy
FCEL
$1.45B
$1.33M 0.39%
+3,972
New +$650K
BABA icon
54
Alibaba
BABA
$276B
$1.29M 0.38%
5,546
+1,590
+40% +$441K
SPGI icon
55
S&P Global
SPGI
$124B
$1.25M 0.37%
3,801
+32
+0.8% +$10.8K
QGEN icon
56
Qiagen
QGEN
$8.62B
$1.25M 0.37%
40,243
-30,585
-43% -$1.63M
CCXI
57
DELISTED
ChemoCentryx, Inc.
CCXI
$1.24M 0.36%
20,014
+18,220
+1,016% +$1.04M
CI icon
58
Cigna
CI
$78.4B
$1.21M 0.36%
5,822
+5,626
+2,870% +$1.1M
COST icon
59
Costco
COST
$432B
$1.21M 0.36%
3,214
-13
-0.4% -$4.86K
BAC icon
60
Bank of America
BAC
$429B
$1.21M 0.36%
39,916
+787
+2% +$21.1K
FCX icon
61
Freeport-McMoran
FCX
$86.2B
$1.19M 0.35%
45,551
+37,795
+487% +$786K
CTRE icon
62
CareTrust REIT
CTRE
$10B
$1.18M 0.35%
+53,232
New +$1.05M
BMY icon
63
Bristol-Myers Squibb
BMY
$129B
$1.18M 0.35%
19,011
-17,572
-48% -$1.08M
RNG icon
64
RingCentral
RNG
$4.83B
$1.17M 0.34%
3,093
-209
-6% -$65K
PG icon
65
Procter & Gamble
PG
$340B
$1.17M 0.34%
8,374
+1,351
+19% +$189K
NOW icon
66
ServiceNow
NOW
$120B
$1.15M 0.34%
10,450
+345
+3% +$35.9K
NXE icon
67
NexGen Energy
NXE
$5.91B
$1.14M 0.33%
413,107
+9,107
+2% +$18.2K
SE icon
68
Sea Limited
SE
$66.4B
$1.14M 0.33%
5,707
+830
+17% +$148K
GDX icon
69
VanEck Gold Miners ETF
GDX
$22.5B
$1.14M 0.33%
31,535
+10,842
+52% +$405K
PTRA
70
DELISTED
Proterra Inc. Common Stock
PTRA
$1.13M 0.33%
+102,307
New +$1.07M
BNO icon
71
United States Brent Oil Fund
BNO
$782M
$1.13M 0.33%
87,496
-23,955
-21% -$272K
WCC
72
WESCO International
WCC
$15.1B
$1.12M 0.33%
+14,264
New +$845K
WELL icon
73
Welltower
WELL
$174B
$1.1M 0.32%
16,998
+4,124
+32% +$250K
AZO icon
74
AutoZone
AZO
$51.3B
$1.09M 0.32%
921
+919
+45,950% +$1.06M
WCN
75
Waste Connections
WCN
$43.6B
$1.09M 0.32%
+10,579
New +$1.09M

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.